Alzheimer's Imaging Consortium
Live session: Friday, July 31, 2020 at 11:30 a.m. Central Daylight Time (North America)
The Alzheimer's Imaging Consortium (AIC) will focus on the clinical application and methodological development of neuroimaging (MRI, PET, SPECT, CT and others) to Alzheimer's disease, other dementias and normal brain aging. The program consists of invited speakers, as well as oral and poster presentations from submitted abstracts.
This session is organized by the ISTAART Neuroimaging PIA.
All clinicians involved in the care or research of individuals with memory or other cognitive complaints, including but not limited to neurologists, psychiatrists, radiologists, geriatricians, neuropsychologists, physicians and nurses; researchers, industry and regulatory agency stakeholders; and others involved in the use of imaging techniques in the study of Alzheimer’s disease, other dementias and normal aging.
Abstract submission has closed.
The agenda will be posted at a later date.
The Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) is a professional society for individuals interested in Alzheimer's and dementia science — including scientists, physicians and other professionals involved in the causes and treatments of Alzheimer's disease and other dementias.
ISTAART membership makes AAIC even better: Receive discounted registration, participate in Professional Interest Areas (PIAs), attend PIA Days scientific sessions before AAIC begins and get access to exclusive members-only scientific and networking events. Members also receive ongoing benefits throughout the year, including an online monthly subscription to Alzheimer's & Dementia®: The Journal of the Alzheimer's Association, free online access to Neurobiology of Aging, access to an online career center, monthly e-newsletters, networking forums and extended LOI deadlines for the Alzheimer's Association International Research Grant Program.
Go beyond the conference — Network and collaborate year-round with a global community of leaders who are working to advance Alzheimer’s and dementia research.